People under 40 years of age cannot use the AstraZeneca coronavirus vaccine, Pakistan’s government has announced under its new guidelines for the use of the Oxford-AstraZeneca vaccine. The restriction for people under 40 years of age is irrespective of gender. Another change in guidelines is that the interval between doses will be 12 weeks instead مزید پڑھیں
زمرہ: صحت
KP to cover liver, bone marrow transplants under Sehat Card Plus Scheme
Khyber Pakhtunkhwa has decided to cover liver and bone marrow transplants for patients under the Sehat Card Plus Scheme, said Chief Minister Mahmood Khan. The decision was taken to provide free treatment facilities to the people and to make the Sehat Card Plus Scheme a comprehensive package of social health protection. The chief minister was مزید پڑھیں
Prescribe medicines with generic and not brand names, DRAP tells Pakistan’s doctors
All provinces have been asked by the Drug Regulatory Authority of Pakistan (DRAP) to make sure doctors prescribe medicines with their generic names in the public and private sectors. DRAP gave the instructions after public complaints on the PM’s Citizen’s Portal against pharmaceutical companies and doctors reportedly colluding to provide people with costlier medicines under مزید پڑھیں
10,000 doses of CanSino coronavirus vaccine wasting away at Karachi warehouse
As many as 10,000 doses of the CanSinoBio coronavirus vaccine developed by China are lying useless at a warehouse in Karachi for the last 10 days as the Drug Regulatory Authority of Pakistan awaits approval to release the vaccines. The single-dose Convidecia vaccine was imported by private company AJM Limited in Pakistan. “This shipment was مزید پڑھیں
US pauses J&J COVID-19 vaccine over rare blood clots
US federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 given the shot developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic. Following the news, Johnson & Johnson (J&J) said it was delaying the rollout of the vaccine to مزید پڑھیں
CanSino coronavirus vaccine: Age limit for single-dose jab changed in Islamabad
The age limit for a single-dose jab of the coronavirus vaccine manufactured by China’s CanSino Biologics Inc, or CanSinoBIO, has been slashed by 10 years in the federal capital. According to the report, the age limit for the CanSinoBIO’s single-dose coronavirus jab has been reduced from 80 to 70 years, meaning that septuagenarians in Islamabad مزید پڑھیں
Islamabad records 16.20 per cent Covid-19 positivity ratio
Islamabad recorded 16.20 per cent Covid-19 positivity ratio during the previous 24 hours, its highest ever since the pandemic began, with 856 new infections. According to the District Health Officer (DHO), 856 new cases of the coronavirus were reported, taking the total number of infections in the federal capital to 56,450 whereas two people succumbed مزید پڑھیں
Hospitals dealing with influx of COVID-19 patients: Dr Faisal
Special Assistant to Prime Minister (SAPM) on Health Dr Faisal Sultan on Saturday cautioned that the situation can go worse if masses continue to violate COVID-19 SOPs. “Currently the hospitals across the country are dealing with the influx of COVID-19 patients,” Dr Faisal Sultan said while addressing a press conference. Observing the highest number of مزید پڑھیں
Anti-coronavirus vaccination of persons above 60 to start from Wednesday: Asad
The vaccination drive for people above 60 years old will begin from Wednesday, March 10, said the National Command and Operations Centre (NCOC) chief Asad Umar on Sunday, adding that further details for the process will be issued tomorrow. In a tweet, the federal minister said that the vaccinations will be done in reverse order مزید پڑھیں
Hospitalized kids with COVID-19 are being affected by Neurologic issues
Most children and adolescents are spared from severe COVID-19, but among those who do require hospitalization, temporary neurologic effects are common, researchers found. In their study of 1,695 patients age 21 or younger hospitalized for COVID-19 or a COVID-19-related illness known as multisystem inflammatory syndrome, 365 – or 22% – had neurologic complications, including 43 مزید پڑھیں
Recent Comments